Galmed Pharma (GLMD) Says ARRIVE Trial Did Not Meet its Primary Endpoint
Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("GalmedĖ® or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
